2607 — Shanghai Pharmaceuticals Holding Co Income Statement
0.000.00%
Last trade - 00:00- HK$41.92bn
- HK$79.74bn
- CNY260.30bn
- 54
- 88
- 34
- 65
Annual income statement for Shanghai Pharmaceuticals Holding Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 186,566 | 191,909 | 215,824 | 231,981 | 260,295 |
| Cost of Revenue | |||||
| Gross Profit | 26,522 | 27,039 | 28,492 | 30,478 | 31,018 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 180,352 | 184,760 | 207,627 | 223,004 | 252,641 |
| Operating Profit | 6,214 | 7,150 | 8,197 | 8,977 | 7,655 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6,262 | 7,175 | 8,144 | 8,808 | 7,054 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,831 | 5,605 | 6,275 | 6,992 | 5,167 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,081 | 4,496 | 5,093 | 5,617 | 3,768 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4,081 | 4,496 | 5,093 | 5,617 | 3,768 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.64 | 1.71 | 1.5 | 1.34 | 1.05 |
| Dividends per Share |